Literature DB >> 7914233

HIV-related oral manifestations in two cohorts of women in San Francisco.

C H Shiboski1, J F Hilton, D Greenspan, J L Westenhouse, P Derish, K Vranizan, A R Lifson, A Canchola, M H Katz, J B Cohen.   

Abstract

The goals of this study were to compare the prevalence of oral lesions in women infected with human immunodeficiency virus (HIV) and HIV-negative women, and to determine the association of oral lesions with route of HIV transmission and with level of immunosuppression in infected women. As part of a prospective 4-year study, oral examinations and blood tests were performed, at 6-month intervals, on 176 HIV-infected women and on 117 HIV-negative women at risk for HIV infection. We evaluated participants for the following oral conditions: hairy leukoplakia, candidiasis, ulcers, warts, non-Hodgkin's lymphoma, Kaposi's sarcoma, and parotid enlargement. As previously reported in men, the prevalence of oral lesions was significantly higher among HIV-infected (22%) than HIV-negative women (3%) [odds ratio (OR) = 8.2; 95% confidence interval (CI) 2.8, 23.5], particularly candidiasis (14%) and hairy leukoplakia (10%). Among HIV-infected women with CD4 cell count nadir > or = 200 cells/microliters, the prevalence of hairy leukoplakia was higher among those infected heterosexually than among injection drug users (OR = 5.5; 95% CI: 1.5; 19). The OR for the association between oral lesions and CD4 cell count nadir (< 200 vs. > 500 cells/microliters) was 8.9 (95% CI: 2.6, 30), indicating a strong positive association with level of immunosuppression.

Entities:  

Mesh:

Year:  1994        PMID: 7914233

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  6 in total

1.  Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.

Authors:  C H Shiboski; H Chen; M A Ghannoum; L Komarow; S Evans; P K Mukherjee; N Isham; D Katzenstein; A Asmelash; A E Omozoarhe; S Gengiah; R Allen; S Tripathy; S Swindells
Journal:  Int J Tuberc Lung Dis       Date:  2014-06       Impact factor: 2.373

Review 2.  Overview of the oral HIV/AIDS Research Alliance Program.

Authors:  C H Shiboski; J Y Webster-Cyriaque; M Ghannoum; J S Greenspan; D Dittmer
Journal:  Adv Dent Res       Date:  2011-04

3.  Oral examination: a screening tool for HIV infection?

Authors:  P G Robinson; S J Challacombe; A Sheiham
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

4.  Incidence and risk factors for verrucae in women.

Authors:  Jacqueline C Dolev; Toby Maurer; Gayle Springer; Marshall J Glesby; Howard Minkoff; Casey Connell; Mary Young; Karlene Schowalter; Christopher Cox; Nancy A Hessol
Journal:  AIDS       Date:  2008-06-19       Impact factor: 4.177

5.  High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group.

Authors:  Caroline H Shiboski; Huichao Chen; Rode Secours; Anthony Lee; Jennifer Webster-Cyriaque; Mahmoud Ghannoum; Scott Evans; Daphné Bernard; David Reznik; Dirk P Dittmer; Lara Hosey; Patrice Sévère; Judith A Aberg
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  Gender differences in oral lesions among persons with HIV disease in Southern India.

Authors:  Umadevi Krishna Mohan Rao; Kannan Ranganathan; Nagalingeswaran Kumarasamy
Journal:  J Oral Maxillofac Pathol       Date:  2012-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.